List view / Grid view




Allergan and Pfizer terminate merger agreement

6 April 2016 | By Victoria White

The decision was driven by the actions announced by the US Department of Treasury to reform inversion tax rules, which the companies concluded qualified as an “Adverse Tax Law Change”. Market rumour suggests that Pfizer will now target Shire or AstraZeneca and shares in both companies went up with the…